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Although the mammalian microbiota is well con-
tained within the intestine, it profoundly shapes
development and metabolism of almost every host
organ. We questioned the range and depth of micro-
bial metabolite penetration into the host, and how
this is modulated by intestinal immunity. Chemically
identical microbial and host metabolites were distin-
guished by stable isotope tracing from 13C-labeled
live non-replicating Escherichia coli, differentiating
12C host isotopes with high-resolution mass spec-
trometry. Hundreds of endogenous microbial com-
pounds penetrated 23 host tissues and fluids after in-
testinal exposure: subsequent 12C host metabolome
signatures included lipidemia, reduced glycolysis,
and inflammation. Penetrant bacterial metabolites
from the small intestine were rapidly cleared into
the urine, whereas induced antibodies curtailed mi-
crobial metabolite exposure by accelerating intesti-
nal bacterial transit into the colon where metabolite
transport mechanisms are limiting. Pervasive pene-
tration of microbial molecules can cause extensive
host tissue responses: these are limited by immune
and non-immune intestinal mucosal adaptations to
the microbiota.
INTRODUCTION
The relationship between mammals and their resident micro-
biota shapes both the microbial communities and every host or-
gan system from conception until death. There are extensive dif-
ferences in all body systems between animals of the same strain
in a germ-free or colonized state (Smith et al., 2007); most effects
of the microbiota are seen if a germ-free animal is colonized atImmunity 49, 545–559, Septe
This is an open access article under the CC BY-Nany age, including but not limited to intestinal secretory immuno-
globulin (Ig)A induction (Gensollen et al., 2016). Given these
ubiquitous interactions over all body systems, it is unsurprising
that almost every disease model has been reported to be sensi-
tive to microbial colonization status (Belkaid and Harrison, 2017;
Blumberg and Powrie, 2012; Sommer and B€ackhed, 2013).
Since thebiomassof themicrobiota iswell separated fromhost
tissues except during pathogenic infections, at first sight it is par-
adoxical that the presence of the microbiota shapes the cellular
composition and function of non-intestinal mammalian organs
so extensively, even when they are almost always sterile. The
answer probably lies mainly in the penetration of microbial me-
tabolites, which in some cases have been shown to exert power-
ful effects on host cell differentiation and metabolism. Microbial
metabolite penetration of host tissues was first shown by detect-
ing aromatic compounds in colonized but not germ-free animals
more than 40 years ago (Cotran et al., 1960; Dayman and Jepson,
1969). Typically, metabolites are inferred to originate frommicro-
bial metabolism when they are present in host tissues only when
animals are fully colonized or harbor specific compositions of
microbial consortia (El Aidy et al., 2013; Nicholls et al., 2003;
Williams et al., 2002). This approach is ambiguous for those com-
pounds that can be synthesized either by host or microbial meta-
bolism, because an increased metabolite concentration after
microbial colonization may be due to the propagation from mi-
crobes or to the host metabolic response to their presence.
Stable isotope tracing to differentiate microbial or host origins
of chemically identical metabolites has so far been used to follow
gut microbial metabolism in an in vitromodel where host effects
are eliminated (de Graaf et al., 2010) or to show selective utiliza-
tion of carbon sources resistant to host digestion by in vivo
incorporation into microbial RNA of a limited number of species
within the intestinal consortia (Tannock et al., 2014). These
labeled nutrient supplementation approaches are thus limited
to spotlighting the fate of individual nutrients within the microbial
communities themselves.
Assessing overall penetration of host tissues with microbial
metabolites requires selective labeling of all microbial (but notmber 18, 2018 ª 2018 The Authors. Published by Elsevier Inc. 545
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
host) molecules, yet avoiding exponential dilution of the label as
bacteria use host or nutritional carbon sources to divide in vivo.
We developed a strategy where germ-free mice are gavaged
with a dose of either 12C- or fully 13C-labeled live E. coli HA107
that cannot replicate in the germ-free intestine (Hapfelmeier
et al., 2010), so the 13C-label is not immediately and exponen-
tially diluted in vivo through bacterial replication using host- or
food-derived 12C nutrients. High-resolution mass spectrometry
(Fuhrer et al., 2017; Se´vin et al., 2017) was then used to reveal
both the 13C host penetration by microbial metabolites and the
12C host metabolome response to the presence of the microbes
in fasting animals. Although E. coli is a minor constituent of the
adult human microbiota, it is a prominent member of the early
life microbiota at a time when diversity is limited (B€ackhed
et al., 2015), and thusmodels some aspects of early-life host-mi-
crobial molecular interactions from a low-diversity microbiota.
A second problem in resolving the in vivo mechanisms that
determine the molecular exchange between intestinal microbes
and their mammalian host is that the intestinal mucosa itself is
extensively reprogrammed by exposure to intestinal microbes
through epithelial cell differentiation, secretion of antibodies,
antibacterial polypeptides, microvascular development, and
xenobiotic metabolic pathway induction (Gomez de Ag€uero
et al., 2016; Hooper et al., 2001; Macpherson et al., 2000; Stap-
penbeck et al., 2002; Vaishnava et al., 2011). This means that mi-
crobes instruct the very mechanisms that build the dynamic
interface separating the host, its intestinal microbes, and their
metabolites. 13C-labeled bacterial challenge of a colonized ani-
mal would largely obscure distinction of microbial and host com-
pounds based on the observed isotopes, because of the much
larger load of natural 12C metabolites from the resident micro-
biota. We have resolved this problem using a system that allows
maturation of the intestinal barrier in germ-free animals through
transient intestinal live microbial preconditioning without perma-
nent colonization (Hapfelmeier et al., 2010). This approach al-
lowed us to compare microbial-host metabolite exchange
directly in fasting germ-free mice, with or without prior
microbial-driven mucosal adaptations including Ig induction.
The combination of this isotope tracing approach and the tran-
sient colonization model has provided a unique insight into
howmicrobial transit through the small intestine and propagation
of microbial metabolites throughout the host are checked by
secretory and metabolic adaptations of the intestinal mucosa.
RESULTS
A Broad Scope of Intestinal Bacterial-Derived
Metabolites Penetrates Host Systemic Organs
While a few microbial metabolites, such as short chain fatty
acids or aryl hydrocarbon receptor ligands, are well known to
shape host metabolism and immune functions (Arpaia et al.,
2013; Gomez de Ag€uero et al., 2016; Perry et al., 2016; Smith
et al., 2013b), we do not know the full extent of microbial metab-
olite penetration, nor the entire scope of consequent host meta-
bolic responses. To assess the propagation of host-microbial
mutualism in 16 mouse tissues and 7 fluids systematically, we
gavaged fully 13C-labeled or 12C live E. coli HA107, which
cannot replicate in vivo, into fasting C57BL/6 germ-free mice
(Figure S1A). By employing high-resolution untargeted mass-546 Immunity 49, 545–559, September 18, 2018spectrometry with high throughput methodology (Fuhrer et al.,
2011, 2017; Se´vin et al., 2017), we resolved more than 1,000 an-
notated compounds (Mr 50–1,000 Da at 1 mD resolution) and
determined the mass shift showing 13C or 12C proportions within
each molecule (Figures S1B and S1C). Molecules from fully 13C-
labeled bacteria (Figures S1D and S1E) showed bacterial
metabolite exposure (Figures S1B and S1F). However, if the
molecule concerned came from the 12C host response rather
than the bacteria (whether or not the challenge bacteria were
13C-labeled), it gave an appropriate mass/charge ratio signal,
but without the 13C mass shift (Figure S1C, illustrated for a hy-
pothetical C4 compound). These experiments can distinguish
host and pre-existing endogenous microbial compounds in fast-
ing mice, rather than products of bacterial metabolism from di-
etary carbon sources.
Two hours after gavage, a wide range of 13C-labeled bacterial
metabolites had already propagated into the host to reach
almost all fluids and organs (Figures 1, 2A–2C, and S2A–S2C).
However, the distribution of different compound classes varied.
Bacterial amino acids (including essential amino acids) pene-
trated very widely over all host tissues (Figures 1 and S2A). Other
bacterial metabolites, including five- and six-membered ring and
heterocyclic compounds, were present in the serum and rapidly
excreted in the urine (Figures 2B and S2C). Urinary lipid amounts
were generally low, consistent with known lipoprotein exclusion
from glomerular filtration (Figures 2B and S2B). Bacterial fatty
acids and glycerolipids were present mainly in the small intesti-
nal tissue and mesenteric lymph nodes (Figure 2C), consistent
with lymphatic uptake. Most compound classes apart from lipids
were able to penetrate into the peritoneal fluid of these naive
germ-free mice (compare analysis of different compound clas-
ses from Figure 2A shown in Figures S2A, S2C, with S2B).
By 18 hr, the front of detected 13C-labeled metabolites had
moved along the intestine to reach the cecum and the colon
(compare Figure 2A insets and S2A–S2F insets at 2 and 18 hr),
consistent with the known murine intestinal transit times (Pad-
manabhan et al., 2013). Although bacterial metabolites had
been cleared from the small intestinal fluid and peritoneum by
18 hr (Figure S2D-S2F), they were still present in small intestinal
tissues (Figure 2C) and being excreted at low amounts in the
urine and the bile (Figure 2B). In many cases the bacterial metab-
olites detected in these unconditioned germ-free mice consti-
tuted a high proportion of the total (bacterial+host) concentration
for that metabolite across different fluids and tissues of the
mouse (Figure S2G).
Since the HA107 system depends on cell wall auxotrophy to
abrogate in vivo replication, we asked whether increased bacte-
rial fragility of the HA107 system generates increased systemic
exposure of bacterial metabolites by comparing penetration of
compounds from HA107 or its non-auxotrophic parent strain.
For maximum sensitivity, challenge bacteria were labeled by
growth in 14C glucose. Although 14C metabolic labeling reveals
only the bacterial origin of the radiolabel but not the original mo-
lecular identity of the bacterial compound, it had the advantage
that we could measure overall 14C transfer, whereas bacterial
replication in vivo would dilute the proportion of 13C-label and
potential underestimation of penetration. We found overlapping
ranges of radiolabel recovery in serum, urine, and host tissues
and no significant differences at most time points, regardless
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Figure 1. Depth of Penetration of 13C-
Labeled Bacterial Amino Acids from the In-
testine to Systemic Sites of the Body
Germ-free C57BL/6mice were gavagedwith 13C- or
12C-labeled HA107 or PBS as control (n = 3–4 mice
per group). Differential ions detected in different
host tissues after 2 hr annotated as fully 13C-labeled
amino acids are indicated where the identical mass
did not exhibit any significant change in the 12C to
PBS comparison (positive Log2-fold change cutoff
of 1 and p value < 0.05). Results are representative
of three experiments. See also Figure S1.of whether or not the test bacteria were engineered with cell wall
auxotrophy (Figures 3A, 3B, and S3A–S3C).
We also confirmed that our method of bacterial gavage into
the stomach in buffer did not result in gastric microbial death.
A single bacterium of the replication competent parent strain of
E. coliHA107was sufficient to permanently colonize the intestine
(Figure S3D). Second, direct measurement recovery of a dose of
1 3 107 CFU HA107 from the luminal contents and mucosal
scrapings of the intestine showed that 85.6% ± 4.4% (x ± SD,
n = 6) of the gavage dose was present in the small intestine
90 min after administration and 73.3% ± 5.1% from the small in-
testine and the cecum 150 min after administration. Third, radio-
label penetration from 14C HA107 or its non-auxotrophic parent
strain was equivalent but substantially less than the same dose
of 14C HA107 material that had been lysed by sonication (Fig-
ure S3E). Hence there was no evidence for immediate gastric
lysis, nor that potential fragility of the employed HA107 strain
would liberate more endogenous metabolites than wild-type
E. coli.ImmWe concluded that there is extensive
penetration of an extremely broad range
of bacterial-derived molecules into host
tissues from the germ-free intestine, even
though live bacteria penetrate only as far
as the local (mesenteric) lymph nodes
(Hapfelmeier et al., 2010). These results
did not distinguish the relative penetration
through the small or large intestinal sur-
faces, nor show how prior mucosal adap-
tation of the germ-free intestine through
secretory Ig induction, antibacterial pep-
tides, and a consolidated barrier function
(Hapfelmeier et al., 2010; Petersson et al.,
2011; Salzman et al., 2010; Vaishnava
et al., 2011) could shape microbial-host
molecular exchange at both small and
large intestinal surfaces.
The Small Intestine Is the
Predominant Interface for
Metabolite Penetration of Intestinal
Microbes
The small intestine has minimal mucus
coverage and is highly adapted for molec-
ular uptake, whereas the large intestinehas a thick layer of protective mucus overlying the epithelium
(Johansson et al., 2008). We compared uptake of 14C HA107 af-
ter delivery into the stomach or after direct in vivo mixing with
cecal contents. 14C labeling was also used in this experiment
to detect host exposure to microbial metabolites with maximum
sensitivity, even if they underwent secondary metabolism in the
host. There was substantial radiolabel uptake from the upper in-
testine and recovery in the urine, but little uptake from cecal bac-
teria (Figures 3A, 3B, and S3A–S3C). This verified that the small
intestine was themain absorptive surface for extensivemicrobial
molecular exchange with host organ systems, and supported re-
sults with the specific molecular 13C system that the urine is a
highly effective immediate elimination route.
The lower small intestine is normally colonized with intestinal
microbes, so microbial molecular exposure has potentially
important biomedical consequences. Mice are naturally copro-
phagic, but even adult humans or infants with reduced intestinal
motility can have high densities of microbes in the proximal small
intestine (Donowitz et al., 2016; Jones et al., 2011). In theunity 49, 545–559, September 18, 2018 547
Figure 2. Penetration of 13C-Labeled Bacte-
rial Metabolites from the Intestine to Host Tis-
sues and Fluids
Germ-free C57BL/6 mice were gavaged with 13C-
labeled HA107 or PBS as control (n = 3–4 mice per
group). Fluid samples were collected 2 or 18 hr later
and analyzed with Q-TOF mass spectrometry. All
ions which were annotated as metabolite isotopes
R75% 13C labeled are plotted.
(A) Left panel shows samples from small intestinal
fluid, peritoneal fluid, serum, and urine at 2 hr; lines
connect identical metabolites. Inset shows small
intestinal, cecal, and colon fluids also at 2 hr. Right
panel shows 18 hr cecal, colon, peritoneal, serum,
and urine fluid samples with (inset) small intestinal,
cecum, and colon fluids.
(B) Cluster analysis heatmap of all 13C-labeled an-
notated metabolites (p < 0.05, R3 mice/group) in
different host fluids at 2 hr and 18 hr after gavage.
Metabolite classes are shown in the lower color bar
and legend. Results are representative of three
experiments.
(C) As for (B), except 13C-labeled annotated me-
tabolites in host tissues are shown.
See also Figure S2.developing world, small intestinal microbes cause childhood
environmental enteropathy with malnutrition and growth stunt-
ing, affecting up to 25% of children aged under 5 years (Korpe
and Petri, 2012).
Maturation of the Intestinal Mucosal Barrier after
Transient Live Microbial Exposure Is Durable and
Involves Immune and Non-immune Transcriptional
Reprogramming
Secretory IgA is known to be induced by small intestinal mi-
crobes (Bunker et al., 2015), and environmental enteropathy is
associated with compensatory secretory IgA responses against
microbes responsible for the loss of intestinal function (Beatty
et al., 1983; Kau et al., 2015). We therefore addressed whether
antibodies or other barrier functions that are induced as a result
of exposure to intestinal microbes constrainmicrobial metabolite
penetration and how this impacts the body metabolome of the
host response.
To assess how mucosal protective factors affect bacterial
metabolite exchange in the intestine, we needed to experimen-
tally uncouple maturation of the mucosa and its barrier functions
from permanent colonization. To confirm the extent of mucosal548 Immunity 49, 545–559, September 18, 2018adaptations after live reversible E. coli
HA107 colonization, we carried out tran-
scriptomic analysis of the intestinal mu-
cosa 2 weeks later, once mice had re-
turned to germ-free status (Figure 3C). In
line with our earlier results demonstrating
a persistent IgA response (Hapfelmeier
et al., 2010), we found a series of signifi-
cantly upregulated Ig transcripts 2 weeks
after transitory exposure to HA107. In addi-
tion, there was upregulation of genes with
known functions in xenobiotic and metalmetabolism, mitochondrial function, ion channels, angiogenesis,
and epithelial microbiocidal peptide expression (Figures 3C and
3D). In a complementary approach, in vivo endomicroscopy was
used to compare the endothelial to epithelial ratios in the small
intestine of transiently colonized and sham control animals (Fig-
ure 3E), consistent with earlier observations of an increased
microvascular density induced by permanent colonization with
Bacteroides thetaiotaomicron (Stappenbeck et al., 2002).
We concluded that even transitorymucosal conditioning by in-
testinal bacteria results in extensive re-programming of immune,
epithelial, and stromal elements of the intestinal mucosa of adult
animals that is durable after the mice have returned to germ-free
status. Thus, in principle we could evaluate the barriers to micro-
bial molecular penetration through the intestine by comparing
secondary bacterial challenge in germ-free mice that had previ-
ously been preconditioned by transient colonization with uncon-
ditioned germ-free controls.
Immunoglobulin Induction Accelerates Small Intestinal
Transit of Bacteria and Their Metabolites
To determine how mucosal adaptation or antibody induction, or
both, affect the depth of metabolite penetration, we compared
Figure 3. Kinetics of Metabolite Penetration and Durable Intestinal Conditioning Responses to E. coli HA107
(A and B) 14C-metabolically labeled E. coliHA107 was administered into the stomach (closed circles) or mixed directly with cecal contents (open circles) of germ-
free C57BL/6mice. For comparison, 14C-labeled E. coli JM83 (replication competent parent strain of HA107; red triangles) was administered into the stomach in a
separate group. 14C-radioactivity in the urine (A) or serum (B) at 2, 8, and 18 hr. Results are expressed as a percentage of the gavage dose/g fluid over background.
(C) RNA-seq analysis of small intestinal tissue from C57BL/6 germ-free mice primed with HA107 transitory colonization 2 weeks earlier, compared with control
germ-free mice. Upper panel: volcano plot shows significantly altered gene expression (padj < 0.05, nR 3) in HA107-preconditioned germ-free mice or in sham-
treated germ-free mice. Immunoglobulin genes are annotated. Expanded box shows a STRING-DB representation of significantly upregulated non-immuno-
globulin genes in preconditioned mice.
(D) Expression of transcripts coding microbiocidal peptides (x ± SEM, nR 3).
(E) Live intestinal microvascular endomicroscopy imaging. FITC-dextran (70 kD) fluorescence was visulized after i.v. injection into HA107-preconditioned C57BL/
6 germ-free and control germ-free mice in the small intestinal villus microvasculature with live Cellvizio endomicroscopy. The x ± SEM of endothelial/epithelial
ratios of each group (n = 6) is indicated (t test p < 0.02). Results are representative of six experiments.
See also Figure S3.germ-free C57BL/6 wild-type with Igh-J-deficient mice lacking
all antibody isotypes due to deletion of the J-segments of
the Ig heavy chain locus (Chen et al., 1993). This avoided theconfounding effects of compensatory intestinal IgM and overin-
duction of systemic IgG in animals selectively deficient for the
IgA isotype (Harriman et al., 1999).Immunity 49, 545–559, September 18, 2018 549
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Figure 4. Transient Intestinal Microbial
Conditioning Enhances Clearance of Bacte-
ria and Their Metabolites from the Intestine
of C57BL/6 Mice Compared with Antibody-
Deficient Igh-J–/– Mice
Germ-free C57BL/6 mice (red) or antibody-defi-
cient Igh-J/ mice (blue) were preconditioned
with HA107 or control treated. Twelve days after
all groups had returned to germ-free status, they
were gavaged with 13C-labeled HA107 or PBS as
control (n = 3–4 per group) and Log2 fold-changes
were calculated (Figure S1Aii).
(A) Samples from small intestinal, cecal, and colon
fluids were collected at 2 hr and analyzed with
Q-TOF mass spectrometry. Differences between
the Log2-fold values of preconditioned and un-
conditioned mice are shown for ions annotated as
metabolite isotopes withR75% 13C labeled. Fold-
changes based on low abundant ions (counts <
200) were excluded. Mann-Whitney U test;
***p < 0.001.
(B) As for (A), but the plot shows individual com-
pound classes.
(C) Small intestinal transit of replication-deficient
bacteria in wild-type mice and antibody-defi-
cient mice. HA107 preconditioned C57BL/6
mice (red symbols) were compared with HA107
preconditioned antibody-deficient Igh-J/ mice (blue) 2 hr after challenging with 107 colony forming units (CFU) HA107 delivered into the stomach. The small
intestine was divided into 10 sections and CFU in luminal contents of each section were determined with auxtrophic supplements (x ± SD n = 3, *p < 0.05).
(D) Whole intestinal transit of replication-deficient bacteria in wild-type mice and antibody-deficient mice. HA107 preconditioned C57BL/6 mice (red symbols) or
antibody-deficient Igh-J/ mice (blue) were gavaged with 108 CFU HA107. Feces were plated with auxotrophic supplements (*p < 0.05). Results are repre-
sentative of two experiments withR6 mice/group.
See also Figure S4.Groups (R18) of germ-free wild-type C57BL/6 and Igh-J/
mice were preconditioned with HA107; separate groups of
each strain were treated in parallel with sterile PBS as controls.
Preliminary experiments established that 14C HA107-treated
mice had no residual detectable radiolabel 14 days after treat-
ment. Two weeks after the preconditioned HA107-treated mice
had returned to germ-free status, theywere divided into 3 groups
ofR6 animals of each strain to be challenged with a single dose
of 13C- or 12C-HA107, or sterile PBS, administered directly into
the stomach (Figure S1Aii). To investigate how antibodies modu-
lated the effect of preconditioning, we compared the relative
difference of positive fold-changes due to propagation of
13C-labeled compounds between pre- and unconditioned
germ-free mice from the C57BL/6 and Igh-J/ strains (Figures
S1B, S1C, 4A, and 4B).
Two hours after bacterial challenge, conditioned C57BL/6
mice showed increased bacterial metabolites in the cecal fluid
and colonic fluid compared with the antibody-deficient Igh-J/
strain (p < 0.001 for all measured compounds and for different
compound classes considered individually in colonic fluid; Fig-
ures 4A and 4B). In contrast, bacterial compoundswere enriched
in the small intestinal fluid of unconditioned mice compared to
conditioned mice (Figure 4A). Since these results were general-
ized across compound classes, we hypothesized that induced
secretory Ig accelerated the transit of intact intestinal bacteria,
either through limiting bacterial motility, reducing adherence,
or exclusion effects.
We verified in our reversible colonization system that
maximum concentrations of secretory IgA directed against in-550 Immunity 49, 545–559, September 18, 2018testinal bacteria were expressed in the small intestine (Fig-
ure S4A; Bunker et al., 2015) and that these IgA antibodies
coated the HA107 challenge organisms and their flagella (Fig-
ures S4B–S4D).
The hypothesis that induced immunoglobulins directly accel-
erate the small intestinal transit of intestinal bacteria was
confirmed by showing faster small intestinal transit (Figure 4C)
and fecal shedding (Figure 4D) of a test dose of HA107 from pre-
conditioned germ-free C57BL/6 mice compared with precondi-
tioned germ-free Igh-J/ controls. By 18 hr, most of the load
of challenge bacteria had been cleared from the colon of
the C57BL/6 wild-type mice. Similar results were obtained
comparing pretreated and non-treated control C57BL/6 mice
(not shown).
Given that isolated loop experiments had showed no differ-
ence in the survival of the bacteria in the intestine whether or
not the animals could express antibodies (Figure S4E), we
considered whether IgA coating of flagella (Figure S4B, enlarged
area) could explain rapid clearance of bacteria from the small in-
testine. Small intestinal secretions contained anti-flagellin anti-
bodies of the IgA isotype (Figure S4F) and intestinal fluid from
preconditioned C57BL/6 but not Igh-J-deficient mice attenuated
the motility of the bacterial strain (Figure S4G and Videos S1 and
S2). Precoating with intestinal fluid from preconditioned C57BL/
6 mice, but not Igh-J-deficient mice, also limited the bac-
terial motility in a motility agar assay (Figure S4H), consistent
with reported monoclonal anti-flagellin inhibition of bacterial
motility (Cullender et al., 2013). While size-exclusion effects
or reduced adherence may also contribute to accelerated
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Cluster 1 (p-value = 0.0078)
Cluster 4 (p-value = 0.016) Cluster 5 (p-value = 0.031)
Cluster 2 (p-value = 0.0078)
Cluster 3 (p-value = 0.016)
E
Cluster 1 (p-value = 0.00049)
Hydroxy hexadecanoic acid [+16] (9)
Heptadecanoic acid [+14][+15]
(3, 4)
Undecanedicarboxylic acid [+12][+13] (1, 2)
Hydroxy-methyl-butanoic acid [+5] (10)
Palmitoleic acid [+16] (8)
Pentadecanoic acid [+14][+15] (5, 6)
Hydroxyestradiol-methyl ether [+18]
(11)
Phenylvaleric acid [+11] (7)
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  annotation (TableS1). 
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antibody-dependent clearance from the small intestine,
increased bacterial motility in the absence of secreted small in-
testinal antibodies potentially allows bacteria to move against
the flow of small intestinal secretions, and hence increases
exposure of the host to their small intestinal metabolites.
Non-immune Mechanisms of Prior Intestinal
Conditioning with Live Microbes Determine the Bodily
Distribution and Excretion of Microbial Metabolites
So far, we had found that without conditioning 13C bacterial me-
tabolites appear in the peritoneal fluid of C57BL/6 and antibody-
deficient mice early after the bacterial challenge (Figures 2A, 2B,
S2A–S2C, 5A, and S5A). However, instead of accumulation in
the peritoneum, there was preferential elimination in the urine af-
ter preconditioning: this effect was antibody independent as it
was seen in both wild-type and antibody-deficient animals (Fig-
ure 5A). At later times there was persistent uptake of bacterial
molecules from the intestine into the serum of conditioned anti-
body-deficient mice (Figure 5B), reflecting the increased dwell
time of bacteria in the small intestine (Figures 4C and 4D). Since
metabolites were very effectively filtered into and concentrated
within the urine, and the lower serum concentrations remain
constant until at least 18 hr (compare Figures 3A and 3B), we
concluded that the general preconditioning response improved
early clearance of metabolites into the urine. Increased cardiac
output and peripheral perfusion have been observed by
comparing germ-free and colonized mice (Smith et al., 2007),
and bacterial pre-conditioning also increases intestinal micro-
vascular density (Figure 3E) which likely favors early metabolite
uptake through the intestinal microvasculature and rapid
clearance into the urine as an antibody-independent effect
(Figure 5A).
From the results showing increased dwell time of bacteria in
the small intestine of antibody-deficient mice, we expected to
detect increased bacterial metabolites in intestinal tissues. This
was found in the small intestine, mesenteric lymph nodes, and
some systemic tissues (Figures 5C and 5D). Specifically, we
found that these bacterial metabolites in the ileum of condi-
tioned antibody-deficient mice included potentially inflammatory
biogenic amine indole derivates such as methoxytryptamine,
methoxytryptophol, methoxydimethyltryptamine, and serotonin
(Figure 5E). In some cases, there was evidence of 12C incorpora-
tion into the dominantly 13C-labeled metabolites (Table S1 spec-
ifies molecular mass-shift results from Figure 5E), indicating
formation after additional host or bacterial metabolism in vivo.
There was also evidence of bacterial saccharides such as arabi-Figure 5. Transient Intestinal Microbial Conditioning Enhances Ant
the Urine
Germ-free C57BL/6 mice (red symbols) or antibody-deficient Igh-J/ mice (blu
status 12 days prior to re-challenge with a gastric dose of fully 13C-labeled or 12C
(A and B) Log2 fold differences between HA107-preconditioned and unconditi
containingR75% 13C are shown for peritoneal fluid, serum, or urine 2 hr (A) or 1
(C and D) As for (B) but showing persistent bacterial metabolites in intestinal (C)
(E) Pairwise Tanimoto chemical similarity indices of more than 1.5-fold increas
antibody-deficient mice. Numbers in squared brackets show mass shifts of ea
metabolite in Table S1. Metabolites with Tanimoto chemical similarityR 0.7 are
U test was applied to calculate the p value of each network.
(F) As (E), except analysis of blood metabolite networks. Results are representat
See also Figure S5.
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not host metabolism (Figure 5E). The serum of conditioned anti-
body-deficient mice contained increased bacterial non-esteri-
fied fatty acids, most of which were fully 13C-labeled (Figure 5F
and Table S1). Increased lipid exposure as a function of coloni-
zation was verified in permanently colonized chow-fed animals
(Figure S5B). It is therefore likely that the bacterial lipid load
makes a substantial contribution to host lipids, particularly in
the context of defective intestinal barrier function.
Natural Antibodies Binding to Microbial Metabolites Are
Induced by Transient Colonization of Germ-free Mice
Given that we had shown binding of induced IgA against the
HA107 transient colonizer, we also addressed whether binding
to any of its bacterial metabolites could be detected. Using
pure compounds selected from the results of the 13Cmass spec-
trometric identifications, we carried out ELISA binding studies
comparing intestinal IgA from C57BL/6 mice and antibody-defi-
cient controls, with and without prior transient colonization. This
showed antibody binding against identified authentic metabo-
lites (Figures 5E and 5F), including heptadecanoic acid, pentade-
canoic acid, scopolamine, and N-acetylaspartylglutamic acid,
with E. coliDNA as positive control andmaltose as negative con-
trol (Figure S5C). These are likely amplified natural specificities
(Bunker et al., 2017) as the binding curves of germ-free and tran-
siently colonized mice superimposed when corrected for IgA
concentration (Figure S5C insets). Nevertheless, natural IgA
per se was insufficient to block the responsiveness of the
mucosa independently of small intestinal bacterial clearance.
Cytokine secretion induced in ileal explants by the presence of
bacteria was affected neither by specific IgA added to the
explant system, nor when the explants themselveswere froman-
imals expressing mucosal IgA (Figure S5D). We concluded that
the principal effect of antibody induction onmetabolite exposure
is to reduce the bacterial dwell time of the sourcemicrobe, rather
than preventing adherence or access of the releasedmetabolites
to the intestinal mucosa.
Persisting Exposure of Antibody-Deficient Mice to
Bacterial Metabolites Results in Increased Host
Cytokine and Metabolomic Responses
Given the pervasive penetration of bacterial-derived metabolites
in many different host tissues in antibody-deficient animals,
including inflammatory triggers such as biogenic amines and
lipids (Figures 5B and 5C), a metabolic and immune host
response was expected. To address this in molecular terms,ibody-Independent Early Clearance of Bacterial Metabolites into
e) were preconditioned with HA107 or control-treated, returning to germ-free
- HA107 as in the Figure 4 legend.
oned germ-free mice for individual annotated ions representing metabolites
8 hr (B) after challenge.
or systemic (D) tissues of antibody-deficient mice at 18 hr.
ed bacterial metabolites (R75% 13C) in ileal tissues at 18 hr of conditioned
ch metabolite and in round brackets denote chemical annotations for each
interconnected and node size shows fold-increase. The paired Mann-Whitney
ive of three experiments.
(legend on next page)
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we exploited the discrimination power of the stable isotope
tracing system by analyzing the changes in 12C metabolite
amounts across different host tissues that were independent of
whether a 13C or 12C bacterial challenge dose had been given
(Figure S1C).
Tissue 12C-metabolite measurements 18 hr after a transient
dose of either 13C-labeled or 12C HA107 showed both increases
and loss of different specific metabolites in intestinal and sys-
temic tissues of conditioned antibody-deficient compared with
wild-type mice (Figures 6A–6C).
The hypothesis that antibody-dependent clearance of bacte-
ria from the small intestine as a mechanism of limiting microbial
metabolite exposure predicted that resulting immune responses
would also be attenuated in vivo. Leukocyte cytokine release
from different immune compartments in preconditioned wild-
type and antibody-deficient mice showed that bacterial rechal-
lenge generated inflammatory and non-inflammatory cytokine
release and that this effect was generally less in conditioned
C57BL/6 wild-type than in antibody-deficient mice (Figure 6D).
Direct stimulation of leukocyte preparations with pure com-
pounds that had been identified earlier as being of bacterial
origin (Figures 5E and 5F) reproduced similar cytokine responses
(Table S2). These results verify clear immunostimulatory effects
from the penetration of the identified bacterial metabolites and
that the functional consequences of exposure are limited by anti-
body secretion.
As many of the compounds shown by their mass spectro-
metric signatures to be of host response origin in the in vivo ex-
periments are not annotated in metabolic pathways, we used
chemical similarity clustering analysis. For example, in anti-
body-deficient ileal tissues, the Tanimoto network of R2-fold
changes comparing HA107-challenged Igh-J/ antibody-defi-
cient mice with unchallenged Igh-J/ controls showed
increased host lysophospholipids, phosphatidic acids, and
non-esterified fatty acids with free head-groups such as arachi-
donic acid (Figure 7A, Table S3). Increased arachidonic
acid-derived host prostaglandins and leukotrienes including
leukotriene E3 and prostaglandins A4, E2, F1a, and F2a were
consistent with innate immune activation (Figures S6A and 7A).
Increased prostaglandins and leukotrienes were also seen in
the pancreas of conditioned antibody-deficient mice at 18 hr,
following likely phospholipid breakdown (Figures 6C, S6A, and
7B). In the blood of antibody-deficient mice, there were also
increased host non-esterified fatty acids, as well as glycinated
fatty acids (Figure 7C), normally associated with lipid overload
and deficient mitochondrial metabolism (Vianey-Liaud et al.,Figure 6. Exaggerated Host Metabolite Responses in Antibody-Deficie
Germ-free C57BL/6 mice (black symbols) or antibody-deficient Igh-J/mice (gre
status 12 days prior to re-challengewith a gastric dose of fully 13C-labeled or 12CH
Annotated ions representing metabolites containing concordant changes from 13
(A and B) Log2 fold-change differences between preconditioned and control m
(B) mesenteric lymph nodes, blood, muscle, and adipose tissues.
(C) Heatmap showing cluster analysis of concordant increases (red) or losses (b
identical metabolite change was seen without a mass shift in both 13C- and 12C-H
metabolite classes. Results are representative of two experiments.
(D) Preconditioned germ-free C57BL/6 mice or antibody-deficient Igh-J/ mice
Total cells isolated from different lymphoid tissues were cultured for 2 hr prior to
experiments with 3–4 mice/group.
See also Figures S6 and S7.
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in fasting mice is (1) of both bacterial and host origin and (2)
can be triggered by antibody-unprotected exposure of the host
to bacterial metabolites in the small intestine.
In contrast, the muscle and the spleen of antibody-deficient
animals showed a loss of esterified and non-esterified lipids
and increased saccharide intermediates (Figures S6B, S7A,
and S7B, Table S3). Fat tissue also showed accumulation of
saccharide intermediates under these conditions (Figure S7C).
These results are consistent with the established effects of lipo-
toxicity on lipid and carbohydratemetabolism triggered by circu-
lating non-esterified fatty acids and eicosanoid signaling (Ertunc
and Hotamisligil, 2016).
To verify the protective importance of the antibody effect on
small intestinal dwell time, we bypassed the effects of microbial
conditioning of the intestinal mucosa and antibody control of
bacterial transit by direct intraperitoneal injection of identified
pure bacterial metabolites. This showed that there were clear re-
sponses in different lymphoid compartments, but these no
longer consistently differed according to whether or not the
mice secrete antibodies, or whether the intestinal mucosa had
been preconditioned (Figure S6C and Table S2).
DISCUSSION
The intestinal microbiota is commonly characterized in terms of
its composition of different taxa: host responses or a disease
phenotype are then correlated with specific taxa or a restricted
range of microbial metabolites. Here we have presented
a systematic analysis of the potential extent and reach of
microbial-host molecular cross-talk from pre-formed endoge-
nous microbial molecules and show that the microbiota itself
induces immune and non-immune boundaries for microbial-
host metabolite penetration. A few microbial taxa, such as
segmented filamentous bacteria, deliver direct signaling through
intimate apposition or attachment to the epithelial suface. Yet
most of the microbial biomass exists in a highly dynamic system
with constant microbial division and death, in the context of
continuous transverse and longitudinal flow along the gastroin-
testinal tract.
Substantial rates of bacterial cell death have been described
under steady-state colonization conditions (Maurice et al.,
2013). We did not find evidence that the cell wall auxotrophy of
HA107 increased the fragility of the organism compared with
its non-auxotrophic parent strain, and we could recover viable
bacteria from fecal samples. Although challenge HA107 bacteriant Mice after Microbial Challenge
en) were preconditioned with HA107 or control treated, returning to germ-free
A107. Tissue sampleswere collected after 18 hr for Q-TOFmass spectrometry.
C and 12C pulsed mice without mass shift were plotted.
ice for each metabolite is shown for (A) duodenal, jejunal, and ileal tissues;
lue) of 12C-host annotated metabolites (p < 0.05, R3 mice/group) where the
A107 challenged antibody-deficient mice. Lower color bar and legend shows
were either re-challenged with a gastric dose of 1010 HA107 or left untreated.
supernatant cytokine analysis. Results are calculated from two independent
Host metabolite response increased in conditioned Igh-J-/- ileum tissue 18 hoursA
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in these experiments were efficiently recovered from the feces,
bacterial death in the mouse intestine certainly contributes to
the metabolite load. This is not restricted to the HA107 model:
in vivo replication rates and overall dynamics indicate high rates
of bacterial death in the intestine (Li et al., 2015; Myhrvold et al.,
2015). Partitioning of bacterial molecules from effete cells into
the host has parallels with symbiosis in the rhizosphere. Never-
theless, given the inflammatory potential of bacterial molecules,
the vulnerability of the host is reduced by antibodies that likely
limit its exposure to metabolites from dead bacteria.
Exposure to intestinal microbes drives durable adaptation of
the intestinal mucosa through immune and non-immune mecha-
nisms. Beneficial effects of intestinal Ig secretion include toxin
and virus neutralization, blocking excessive live bacterial translo-
cation, clearance of unwanted macromolecular structures at the
epithelial surface, and directed sampling of luminal antigen
(Macpherson et al., 2018). Lack of specific IgA has been shown
to increase transcriptional evidence of innate immune system
activation in the intestine (Peterson et al., 2007). We now show
that antibody induction and secretion decreases microbial
motility, accelerates in vivo intestinal transit, and limits exposure
of the small intestinal mucosa to the pro-inflammatory molecular
constituents of intestinal microbes. Only extremely low titers of
specific serum IgG occur after intestinal preconditioning (Gomez
de Ag€uero et al., 2016); we therefore tested the elimination of all
antibody isotypes to avoid the compensatory effects of IgM
secretion and increased IgG induction in IgA deficiency (Harri-
man et al., 1999) or the enteropathy that occurs with polymeric
immunoglobulin receptor deficiency (Johansen et al., 1999). It
is likely that affinity matured secretory IgM can compensate
IgA, and a role for IgG isotypes is not excluded.
These effects are poised on the small intestinal mucosa, where
limiting bacterial metabolite uptake must be set against the ne-
cessity for nutrient absorption. In humans in the developedworld,
the lower small intestine has a microbial biomass of up to 107 or-
ganisms/mL intestinal contents. Globally, microbial colonization
of the small intestine remains a severe problem. One of the
most urgent biomedical problems of our age is to understand
why the presence of high densities of small intestinal microbes
in children from the undevelopedworld causes intestinal dysfunc-
tion and infantmalnutrition that cannot be adequately treatedwith
caloric increases (Kau et al., 2015; Smith et al., 2013a). Compen-
satory IgA that limitsmicrobialmetabolite exposurebydecreasing
the small intestinal dwell timemay contribute to the protective ef-
fect for taxa that do not attach to or invade the epithelium. Reduc-
tion in an intestinal clearance effect is also consistent with the
small intestinal lymphonodular hyperplasia in the setting of IgA
and affinitymatured IgM deficiency, owing to a deletion of activa-
tion-induced cytidine deaminase (Fagarasan et al., 2002).
We have distinguished bacterial metabolite exposure and
resultant host responses with extremely wide coverage, evenFigure 7. Tanimoto Chemical Similarity Networks of Increased Metabo
bial Challenge
Tanimoto chemical similarity indices of increased host response metabolites in b
analyzed as described in Figure 5. Networks from the ileum (A), the pancreas (B
Numbers in squared brackets correspond to chemical annotations for each met
difference between conditioned and control germ-free Igh-J/. Paired Mann-W
representative of two independent experiments with 3–4 mice/group. See also F
556 Immunity 49, 545–559, September 18, 2018where the same molecule can be derived from either bacterial
or host metabolism. The results attest to pervasive microbial
metabolite exposure, over many classes of metabolites,
including increased bacterial lipid penetration. A high proportion
of the penetrant microbial metabolites were very rapidly
excreted in the urine, although there were also durable in-
creases, some of which benefit the host, such as essential amino
acids. To be able to interrogate bacterial metabolite penetration
at the same time as the host molecular response using stable
isotope tracing, the model was limited to a single taxon;
metabolite exposure from other taxa may vary according to
their frequencies, flagellate statuses, and metabolic pathway
differences.
While the breadth of metabolic exchange allows a broad port-
folio of metabolic responses, the predominant effect in antibody-
deficient fasting mice was lipidemia of both microbial and host
origin, and host lipid breakdown in the intestine and the muscle.
Breakdown of phospholipid components in the intestine was
also accompanied by prostaglandin and leukotriene synthesis.
Extending our model could potentially separate host or dietary
molecular effects from microbial molecular effects in the fed as
well as the fasting state.
A substantial investment of metabolic energy is made in the
secretory IgA response which comprises approximately 75% of
all immunoglobulin production in mammals (Macpherson et al.,
2008), most of which is secreted in the small intestine. The
small intestine is a delicately positioned interface with the envi-
ronment. On one hand, it is specialized for uptake of nutrients
with minimal mucus covering and a combination of digestive
and secretory mechanisms. Some of these nutrients are prod-
ucts of microbial metabolism, including vitamins, short chain
fatty acids, and compounds capable of receptor signaling
mechanisms that mature host organ systems (Gomez de
Ag€uero et al., 2016). On the other hand, the small intestine
must handle the inevitable contamination with intestinal mi-
crobes that expose the host to a range of compounds that
potentially result in innate immune activation: this it does with
a combination of physiological adaptations to clear microbial
compounds quickly into the urine and secretory immunoglobu-
lins accelerating transit away from the susceptible small intes-
tinal mucosa, thereby modulating both microbial penetration
into the host and the resultant host immune and metabolic
responses.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Germ-free C57BL/6(J) and Igh-J/ (Chen et al., 1993) mice were born and maintained in flexible-film isolators in the Clean Mouse
Facility, University of Bern, Switzerland. Age and gender-matchedmicewere used at 10-12weeks for themetabolomics samplings in
this study. All mice were independently confirmed to be pathogen-free. They were also verified germ-free within the breeding iso-
lators and during experiments (apart from the transient colonization and the colonized experiment shown in Figures S5B and
S5C) by culture-dependent and -independent methods. All mouse experiments were performed in accordance with Swiss Federal
and Cantonal regulations.
Microbe strains
Escherichia coliHA107 was constructed as an auxotrophic E. coli strain lacking synthetic capabilities of two amino acids, meso-DAP
and D-alanine (Hapfelmeier et al., 2010). It grows equivalent to wild-type E. coli via supplementing with 100 mg/mL meso-DAP and
400 mg/mL D-alanine in vitro, and only transiently colonizes germ-free mice due to its auxotroph (Hapfelmeier et al., 2010).
METHOD DETAILS
Preconditioning the intestinal mucosa through transient bacterial colonization in germ-free mice
E. coli HA107 bacterial overnight cultures were centrifuged at 3480g for 10 min at 4C. After washing twice with sterile PBS, the
required dose of bacteria was resuspended in PBS (1010 CFU per 500 ml). The bacterial solution was gavaged directly into the mouse
stomach on alternate days four times. One week after the last HA107 gavage, the feces from the mice were routinely verified by cul-
ture-dependent and -independent methods to be germ-free. Control germ-free mice were similarly treated in parallel throughout,
although gavaged with an equivalent volume of sterile PBS. Preconditioned mice were studied further 14 days after the last condi-
tioning dose.
Preparation of 13C-labeled bacteria
To prepare 13C-labeled HA107, sterile 13C-labeled bacterial extracts from E. coliMG1655 were used as source of 13C-labeled amino
acids and vitamins. For this, E. coli MG1655 was initially cultured in M9 medium using 13C-D-glucose (Cambridge Isotope Labora-
tories) as sole carbon source. After three sequential subcultures, fully 13C-labeled MG1655 bacterial extracts were obtained and
sterilized by filtration (0.22 mm). E. coli HA107 was then cultured in M9 medium containing 13C-D-glucose and 13C-labeled bacterial
extracts from E. coliMG1655. After three sequential cultures, the HA107 bacterial culture was centrifuged at 3480 g for 10min at 4C.
After washing twice with sterile PBS, the required dose of HA107 bacteria was suspended in PBS (1010 CFU per 500 ml). We verified
that this protocol achieved essentially complete (> 90%) 13C-labeling of the carbon chains of all bacterial molecules across all com-
pound classes (Figures S1D and S1E).
Mass spectrometry
Samples were snap-frozen in liquid nitrogen. To prepare fluid samples for mass spectrometry, weighed fluid samples (50 mg) were
precipitated with final 80% methanol for 1 hour at 20C. After centrifugation at 20,000 g for 10 min at room temperature, the su-
pernatant was transferred toQ-TOF plates. To prepare tissue samples for mass spectrometry, metabolites fromweighed tissue sam-
ples (50 mg) were extracted with 20 times weight of Millipore water (80C) followed by homogenization at 25 Hz for 2 min in a tissue
homogenizer (Retsch MM 400) with a clean steel ball (Berani). After centrifugation at 20,000 g for 10 min at room temperature, su-
pernatants were transferred to Q-TOF plates.
Quantification of relative metabolites concentrations was carried out with an Agilent 6550 Q-TOF mass spectrometer (Agilent
Technologies Inc., Santa Clara, CA) by non-targeted flow injection analysis as described previously (Fuhrer et al., 2011). Profile
spectra with high mass accuracy were recorded from 50 to 1000m/z in negative ionization mode. The commonmass axis after sam-
ple alignment was recalibrated using known frequently occurring metabolite ions. Ions were finally annotated based on accurate
mass comparison using 1 mDa mass tolerance against 9261 unique metabolites present in a pooled list of compounds derived
from the Human Metabolome Database (Wishart et al., 2013), E. coli genome scale-model (Orth et al., 2011) and the E. coli Metab-
olome Database (Sajed et al., 2016). All potentially possible 13C isotopes were annotated taking into acount the respective summass
formula.
Determining the extent of 13C-labeling in E. coli HA107 used for stable isotope tracing
The free intracellular metabolites were extracted from the cell pellet with Millipore water at 80C and analyzed by non-targeted flow
injection analysis as described above. Proteinogenic amino acids were obtained from the extracted pellet after hydrolysis with 6 MImmunity 49, 545–559.e1–e5, September 18, 2018 e2
HCl and subsequently derivatized with N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide as described previously (Nanchen
et al., 2007). The 13C-labeling patterns were then determined on a 6890N Network GC system with a 5975 inert XL mass selective
detector (Agilent Technologies Inc., Santa Clara, CA). Fractional label for both intracellular metabolites and proteinogenic amino
acids was then estimated from the relative abundances of m0 and mmax ion counts as mmax / (m0 + mmax).
Metabolomics data analysis
Log2 fold-changes of
13C-labeled compounds were calculated from the division of [positive ion counts at m+x isotope annotation
from 13C-HA107 gavaged samples] by [ion counts at m+x isotope annotation from PBS gavaged samples]. DLog2 fold-change
was calculated from the subtraction of [Log2 fold-change of germ-free control mice] from [Log2 fold-change of conditioned mice].
Log2 fold-changes of
12C compounds in 13C-HA107 gavaged samples were calculated from the division of [ion counts at m0 anno-
tation from 13C-HA107 gavaged samples] by [ion counts at m0 annotation from PBS gavaged samples]. In the same way, Log2 fold-
change of 12C compounds in 12C-HA107 gavaged samples were calculated from the division of [ion counts at m0 annotation from
12C-HA107 gavaged samples] by [ion counts at m0 annotation from PBS gavaged samples]. For the host response of endogenous
12C compounds, compounds with the same direction of Log2 fold-change in both Log2 fold-change of
12C compounds in 13C-HA107
gavaged samples and Log2 fold-change of
12C compounds in 12C-HA107 gavaged samples were taken. Where shown, the
Metamapp program was used to evaluate the Tanimoto chemical similarity index on compounds selectively present in one condition
applying Cytoscape software for network visualization. Mann Whitney U test was performed using wilcox.test function in R (* = p <
0.05, ** = p < 0.01, *** = p < 0.001).
Preparation of 14C-labeled bacteria
M9medium supplemented with 100 mg/mLmeso-DAP, 400 mg/mLD-alanine, 10 mg/mL lysine, 10 mg/mL threonine, 10 mg/mLmethi-
onine, 10 mg/mL proline, 4 mg/mL thiamine, 2 mM L-arabinose, and 5 mM succinate was inoculated with 1/100th amount of E. coli
HA107 (or JM83) overnight culture grown in LBmedium. The culture was incubatedwith shaking at 180 rpm at 37C.When the culture
reached OD600 0.28 ± 0.05, 2-[1-
14C]-deoxy-D-glucose (Perkin Elmer) was added. The bacterial culture was further incubated for
12-14 hours at 37C. After harvesting the bacterial culture, the bacterial pellet was washed twice with PBS to remove unincorporated
14C-radioactive materials and resuspended prior to gavage.
Cecal injection
For cecal injection mice were anaesthetized with isoflurane by inhalation (3.0 to 4.0% v/v isoflurane from a vaporizer with O2 flow at
1-2 L/min). An incision (1 cm)wasmadewith curved scissors at left side of lower abdomen, and the cecumwas located. 14C-labeled
HA107 was injected into the middle of cecum and mixed thoroughly with the contents. The abdominal incision was closed with
AUTOCLIP Wound Clip System (BD). Temgesic (0.05-0.1 mg/g body weight) was injected subcutaneously for analgesia.
Liquid scintillation counting
Weighed samples were incubated with 1 mL of NCS Tissue Solubilizer (GE Healthcare) at 56C until completely dissolved. The pH
was neutralized with 200 ml of 100% acetic acid. Ultima Gold liquid scintillation cocktail (18 ml, PerkinElmer) was added to each sam-
ple. The 14C-radioactivity in each sample was measured in a TRI-CARB 2300TR Liquid Scintillation Analyzer (Packard). Scintillation
background for each fluid or tissue type was subtracted using matched samples from control germ-free mice that had not received
14C-labeled bacteria.
RNA isolation
Tissue samples were snap-frozen in TRIzol reagent (Invitrogen) using liquid nitrogen. Thawed tissues in TRIzol reagent were imme-
diately homogenized at 25 Hz for 2 min in a tissue homogenizer (Retsch MM 400) with sterile steel balls (Berani). Total RNA was iso-
lated following the standard protocol from Invitrogen. The total RNA was further purified with RNeasy MinElute kit (QIAGEN). RNA
quality was assessed on a Bioanalyzer 2100 (Agilent). Ribosomal RNA was removed with Ribominus Transcriptome Isolation Kit (In-
vitrogen). RNA libraries were prepared with TruSeq RNA sample preparation v2 kit (TruSeq Stranded mRNA Sample Preparation,
Illumina). RNA sequencing was performed with Illumina HiSeq 2500 using the 150bp paired-end mode. Read quality control was
with FastQC. Each read was mapped onto the mouse genome using TopHat2. Counts per gene were assessed using HTSeq-count
software. Differential gene expression analysis was performed using DESeq2. Adjusted Log2 fold-change and adjusted p-values
(corrected for multiple testing) were used to determine significant differences in gene expression. Functional protein association net-
works of genes of adjusted p-value of < 0.05 were analyzed using the STRING database (version 10) taking network confidence
scoresR 0.4.
Live intestinal endomicroscopy
Mice investigated with endomicroscopy were anaesthetized with isoflurane inhalation as described for cecal injection on a heating
pad at 37C. The abdomen of the anaesthetized mouse was opened and a Cellvizio confocal miniprobe (Mauna Kea) was inserted
into the intestinal ileal lumen. Fluorescein isothiocyanate (FITC)-dextran (0.5 mg, 70 kDa, Sigma) in PBSwas injected intravenously to
provide real-time vascular contrast. The fluorescence of FITC in the intestinal vasculature was recorded with Cellvizio software
(Mauna Kea). Metrics of the endothelial and epithelial layers were evaluated with ImageJ software (NIH).e3 Immunity 49, 545–559.e1–e5, September 18, 2018
Enzyme-linked immunosorbent assay (ELISA)
The gastrointestinal tracts from HA107 conditioned germ-free C57BL/6 mice were separated according to section (duodenum,
jejunum, cecum and colon). Isolated luminal contents from each section were weighed. IgA concentration was measured with ELISA
using goat anti-mouse IgA (Bio-Rad Antibodies) coating antibody. The detection antibody was HRP-conjugated anti-mouse IgA
(Sigma). Standards were myeloma-derived purified IgA (Hycult). The IgA concentration in the contents of each germ-free intestinal
segment was plotted.
Bacterial immunofluorescent staining
E. coliHA107 was cultured without shaking at 37C for overnight. The bacteria were then washed in PBS and resuspended at 107 per
ml. Portions (50 ml) of the bacterial suspension were dropped onto glass slides and the bacterial drop was encircled using a wax pen.
Bacteria were allowed to sediment onto the glass slides and to dry. Transiently flamed bacteria on glass slides were stained with
intestinal wash prepared from small intestine of HA107 conditioned germ-free C57BL/6 mice. The IgA antibodies bound to bacteria
were visualized with FITC-conjugated anti-mouse IgA (BD Bioscience). DAPI (4’, 6-diamidino-2-phenylindole) was used to counter-
stain the bacterial DNA. Immunofluorescent pictures were taken using Flash Slide Scanner (PerkinElmer) with 40 magnifications.
Bacterial motility assay
E. coli expressing GFP constitutively were resuspended at 108 CFU/mL with PBS-based intestinal wash from either HA107 condi-
tioned C57BL/6 or Igh-J / mice. Bacteria were then loaded to microfluid chips. Serial pictures were taken every second over
5 min by Zeiss LSM 700 confocol microscope. The images were transformed into time-lapse videos with Volocity software
(PerkinElmer).
Bacterial intestinal transit time
Germ-free C57BL/6 and Igh-J /mice were conditioned with HA107 as described previously. For small intestinal transit, 107 CFU of
HA107 were introduced directly into the stomachs of mice. Two hours after the intragastric gavage, small intestines were collected
and separated into 10 sections of identical length from duodenum to ileum. All luminal contents in each section were plated on LB
agar plates with the auxotrophic supplements and results were evaluated for each segment. Tomeasure whole intestinal transit time,
1010 CFU of HA107 were introduced to the stomachs of mice. Feces were sequentially collected and cultured as described
previously.
Metabolite-specific ELISA
Metabolite-specific ELISA was performed to address the binding of intestinal IgA to purified identified metabolites including penta-
decanoic acid (Sigma); 5-methoxytryptamine (Sigma); N-acetylaspartylglutamic acid (Sigma); scopolamine hydrochloride (Sigma);
D-maltose (VWR) and heptadecanoic acid (Sigma). E.coli LPS (Sigma) and DNA from E. coliwere used as controls. ELISA plates (Mil-
ian) were coated with 50ml/well of 10mg/mL antigen overnight (ON) using coating buffer (0.1M NaHCO3) except pentadecanoic acid
and heptadecanoic acid coated using 100% ethanol. After blocking (PBS with 2%BSA, RT, 2h), serial diluted intestinal washes con-
taining IgA were added to the plates and incubated for 2 hours. To reveal the IgA binding affinity to metabolites, HRP conjugated
anti-IgA antibody (1:100, Sigma) was added to each well and incubated for 45 min. Plates were then washed (4X, PBS containing
0.5% Tween-20) and developing reagent (100 mL per well, 1mg ABTS plus 5ml H2O2/10ml 0.1 M NaH2PO4) was added. Samples
then were read at OD415 using an ELISA plate reader.
Cytokine release assays
Mice used in cytokine release assays were preconditioned with HA107 as described in Method Preconditioning. Peritoneal cells
were collected by gentle flushing of the peritoneal cavity with RPMI 1640 medium; splenocytes, mesenteric lymph node cells
(MLN cells) and bone marrow cells harvested from mouse femur were isolated using a 100mm cell strainer. After red blood cell lysis,
2 3 106 cells/mL were prepared in complete medium (RPMI 1640 with 10% FBS, 50 mM b-mercaptoethanol, 100 U/mL penicillin/
streptomycin and 2mM HEPES). A 100ml suspension was seeded in each well of 96-well cell culture plates (Thermo Fisher). The
natural cytokine release from cells was determined after incubating at 37C supplemented with 5% CO2 for 2 hours. For in vitro
stimulation with metabolites/bacteria-derived components, 250mg/mL of each compound as listed was added to the culture and in-
cubation was carried out for 6 hours. The culture supernatants were collected for further analysis.
Intraperitoneal challenge with pentadecanoic acid or 5-methoxytryptamine
Mice were preconditioned with HA107 or left untreated. Two weeks after the last oral bacterial priming, mice were intraperitoneally
injected with 1mg/kg body weight pentadecanoic acid or 5-methoxytryptamine. 6 hours after injection, cells were isolated from indi-
cated lymphoid organs and cultured for 2 hours. The supernatants were collected for further analysis.
Cytokine quantification
Cytokinemeasurements were performed using theMeso Scale Discovery (MSD) system. Samples were initially diluted 1:1 with com-
mercial MSD diluent buffer and added into Meso Scale 19-plex plates. Serial titrations of cytokine standards were also added to the
plates. After overnight incubation, plates were washed (3X, PBS with 0.5% Tween-20) and a panel of commercial 19 secondaryImmunity 49, 545–559.e1–e5, September 18, 2018 e4
antibodies was added to plates and incubated for 2 hours following the manufacturer’s protocol and instructions. Plates were then
washed (3X, PBS containing 0.5% Tween-20), and 150ml substrate buffer was added into each well. Plates were then read on Meso
Scale plate reader.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the definitions and exact values of n (e.g., number of experiments, number of mice, etc) and distri-
butions are reported in the Figure Legends. Mann-Whitney U test was used for all metabolomic comparisons and unpaired student-t
test was performed in intestinal transit tests andmicrobial culture related tests. Statistical analysis was performed in GraphPad Prism
and R software. In all figures: * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
DATA AND SOFTWARE AVAILABILITY
The RNA sequencing data files have been deposited in the NCBI Gene Expression Omnibus under accession number
GEO:GSE102543. String analysis (https://string-db.org/) has been used to elucidate the RNA sequencing data. All original metab-
olomic data are available at http://www.mucosalimmunology.ch/de/The-lab-University-of-Bern/Supplementary-resources-of-
Publications.e5 Immunity 49, 545–559.e1–e5, September 18, 2018
